Invesco Ltd. Verrica Pharmaceuticals Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Invesco Ltd. holds 423,520 shares of VRCA stock, worth $3.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

423,520

Holding current value

$3.37 Million

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 13, 2024	BUY	$5.89 - $9.56 $2.49 Million - $4.05 Million	423,520 New	423,520 $3.09 Million
Q2 2023 Aug 11, 2023	BUY	$5.32 - $6.79 $56,711 - $72,381	10,660 New	10,660 $61,000

Others Institutions Holding VRCA

# of Institutions

Shares Held

17.4M

Call Options Held

6.1K

Put Options Held

6.3K

Perceptive Advisors LLC New York, NY

7.1M
Shares

$56.4 Million
1.5% of portfolio
Avoro Capital Advisors LLC New York, NY

4M
Shares

$31.8 Million
0.4% of portfolio
Vanguard Group Inc Valley Forge, PA

1.27M
Shares

$10.1 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.13M
Shares

$8.98 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

463K
Shares

$3.68 Million
0.0% of portfolio

View Full List

About Verrica Pharmaceuticals Inc.

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

More about VRCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account